Takayuki Hamano Selected Research

maxacalcitol

1/2021	Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity.
4/2018	Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.
12/2012	Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.
8/2009	Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takayuki Hamano Research Topics

Disease

28	Chronic Renal Insufficiency 01/2022 - 11/2006
14	Vascular Calcification 01/2020 - 02/2005
12	Proteinuria 03/2022 - 08/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 10/2012
10	Anemia 04/2022 - 02/2014
9	Secondary Hyperparathyroidism 01/2022 - 01/2008
9	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2020 - 04/2009
8	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 03/2008
7	Heart Failure 12/2021 - 01/2015
7	Neoplasms (Cancer) 11/2020 - 10/2012
6	Kidney Diseases (Kidney Disease) 03/2022 - 02/2004
6	Inflammation (Inflammations) 03/2022 - 01/2016
6	Vitamin D Deficiency 01/2022 - 05/2007
6	Osteoporosis 01/2022 - 09/2005
5	Diabetes Mellitus 03/2022 - 11/2009
5	Hyperphosphatemia 01/2022 - 05/2012
5	Infections 01/2021 - 12/2015
5	Fibrosis (Cirrhosis) 01/2021 - 12/2012
4	Renal Insufficiency (Renal Failure) 03/2022 - 05/2009
4	Peritonitis 01/2022 - 12/2007
4	Hypercalcemia (Milk Alkali Syndrome) 01/2021 - 02/2005
4	Malnutrition (Nutritional Deficiencies) 10/2020 - 05/2007
4	Hypocalcemia 10/2020 - 09/2016
4	Myocardial Infarction 08/2018 - 01/2014
3	Body Weight (Weight, Body) 03/2022 - 01/2015
3	Hyperparathyroidism 01/2022 - 05/2012
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020 - 05/2007
3	Bone Fractures (Bone Fracture) 12/2019 - 06/2006
3	Bone Resorption 07/2009 - 06/2006
2	Water Intoxication 03/2022 - 01/2021
2	IGA Glomerulonephritis (IGA Nephropathy) 03/2022 - 08/2010
2	Hyponatremia 12/2021 - 02/2021
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 01/2018
2	Atrophy 01/2021 - 01/2019
2	Peritoneal Fibrosis 01/2021 - 12/2007
2	Pneumonia (Pneumonitis) 11/2020 - 01/2020
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2020 - 01/2013
2	Glomerulonephritis 01/2020 - 01/2013
2	Iron Deficiencies 01/2019 - 06/2015
2	Insulin Resistance 02/2017 - 05/2007
2	Hypophosphatemia 10/2012 - 06/2011

Drug/Important Bio-Agent (IBA)

20	Vitamin D FDA LinkGeneric 01/2021 - 02/2005
19	Phosphates (Orthophosphate)IBA 01/2022 - 09/2005
17	CalciumIBA 10/2020 - 02/2005
13	Parathyroid Hormone (Parathormone)IBA 01/2022 - 05/2007
12	Fibroblast Growth Factor-23IBA 01/2022 - 04/2009
10	MagnesiumIBA 01/2019 - 05/2009
9	MineralsIBA 01/2019 - 05/2009
7	hydroxide ionIBA 03/2022 - 05/2007
6	Hemoglobins (Hemoglobin)IBA 04/2022 - 12/2014
6	25-hydroxyvitamin DIBA 01/2022 - 05/2007
6	GlucocorticoidsIBA 01/2022 - 09/2005
6	Dialysis SolutionsIBA 08/2018 - 02/2005
5	SodiumIBA 04/2022 - 02/2014
5	Cinacalcet (Sensipar)FDA Link 01/2022 - 04/2009
5	AlbuminsIBA 01/2021 - 01/2018
5	CreatinineIBA 01/2021 - 08/2010
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2003
4	IronIBA 03/2022 - 06/2015
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2009
4	maxacalcitolIBA 01/2021 - 08/2009
4	Phosphorus (Red Phosphorus)IBA 01/2019 - 12/2013
4	Diphosphonates (Bisphosphonates)IBA 11/2018 - 06/2006
3	Tolvaptan FDA Link 12/2021 - 01/2015
3	Erythropoietin FDA Link 10/2019 - 03/2008
3	Alkaline PhosphataseIBA 01/2019 - 06/2012
3	Therapeutic UsesIBA 01/2018 - 06/2006
3	Pharmaceutical PreparationsIBA 09/2016 - 01/2008
3	1,25-dihydroxyvitamin DIBA 12/2013 - 01/2012
3	alpha-2-HS-GlycoproteinIBA 03/2013 - 05/2009
3	Calcitriol (Calcijex)FDA LinkGeneric 08/2009 - 08/2008
3	Collagen Type I (Type I Collagen)IBA 11/2006 - 09/2005
2	HematinicsIBA 04/2022 - 01/2019
2	Methylprednisolone FDA LinkGeneric 03/2022 - 01/2020
2	Cholecalciferol (Vitamin D3)FDA Link 01/2021 - 01/2020
2	Transferrin (beta 2 Transferrin)IBA 01/2021 - 06/2015
2	Ferritins (Ferritin)IBA 01/2021 - 06/2015
2	ElectrolytesIBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2020 - 01/2015
2	ChloridesIBA 01/2020 - 12/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 10/2017
2	LDL CholesterolIBA 01/2019 - 01/2016
2	Raloxifene Hydrochloride (Evista)FDA Link 11/2018 - 03/2010
2	Polymethyl Methacrylate (Sol)IBA 01/2017 - 01/2017
2	Tartrate-Resistant Acid PhosphataseIBA 11/2016 - 07/2009
2	DiureticsIBA 01/2015 - 01/2015
2	Selective Estrogen Receptor Modulators (SERM)IBA 03/2010 - 06/2006
2	Risedronic Acid (Actonel)FDA LinkGeneric 06/2007 - 09/2005
2	collagen type I trimeric cross-linked peptideIBA 11/2006 - 06/2006
1	Glucose (Dextrose)FDA LinkGeneric 04/2022

Therapy/Procedure

22	Renal Dialysis (Hemodialysis) 01/2022 - 02/2005
16	Therapeutics 03/2022 - 11/2006
7	Peritoneal Dialysis 01/2022 - 12/2007
3	Kidney Transplantation 01/2022 - 10/2012
3	Parathyroidectomy 01/2022 - 04/2009
2	Enzyme Replacement Therapy 01/2022 - 12/2021
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 11/2020
2	Transplantation 01/2021 - 01/2020
2	Catheters 12/2016 - 12/2015
2	Hemodiafiltration 12/2016 - 12/2015